Why I’d Buy Canopy Growth Corp. at $7

Long or short, Canopy Growth Corp. (TSX::CGC) is a bargain at $7.

| More on:

The recent selling in Canopy Growth Corp. (TSX:CGC) is a test of an investors’ mettle. Canopy Growth has been as high as $16 and change intraday. Recently, it has traded down to $8 or so. Is it time to fade the stock or is it time to buy?

When a new stock like Canopy Growth is traded on future values in a new industry, it is difficult for the market to decide its proper valuation because there are no accepted standards of measure. In 1997 Amazon.com, Inc. (NASDAQ:AMZN) IPO’d at $18 per share and surged during the dot com boom before trading as low as $8 by 2002. Facebook debuted at $42 in May 2012 before trading down to less than $18 per share by September of that year.

The reason these “super stocks” traded with so much volatility is twofold: (1) no one fully understood the economic model that these businesses were using in a new industry; and (2) short sellers and “big money” faded the stock price, so they could scare out nervous speculators, make money on their short position, while simultaneously engineering their own low entry price into the equity.

These same dynamics seem to be at work in Canopy Growth’s case.

Marijuana and its derivative cannabinoid products have been known, anecdotally, to have medicinal powers. However, until quite recently, the medicinal effects have not been examined scientifically. That fact has changed; currently, millions of people use marijuana for what ails them. Evidently there is a business to be modeled, but the science to back it is still in development.

However, big pharma and other skeptics still abound. Unsurprisingly, major competitors and naysayers are the natural cheerleaders of any short-selling campaign, as are many profit-seeking day traders.

Short sellers always fade stocks where the fundamentals are outpaced by the company’s high valuation. Canopy Growth makes no profit at this point, which gives the shorties plenty of ammunition to buttress their argument. Amazon never made any real profits for almost 20 years, while they spent their capital building their physical infrastructure. In the long run, this lack of profits didn’t harm Amazon’s equity price as patient investors began to understand the Amazon business model.

I would buy Canopy Growth at $7, $6, or even $4, if the stock ever got that low again.

Canopy Growth is a leader in a new industry that is growing. I can’t imagine that, in today’s debt-strangled world, how cannabis as a medical product can fail. A new drug that is organic, effective for many health ailments, and costs significantly less than its competitors can’t be stopped or even slowed by governments, regulators, or big pharma.

I can foresee a 50/50 chance that Canopy Growth will be taken over by a mainstream big pharma corporation within five years. I strongly believe that the take-out price would be well north of $7 per share.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Drew Currah has no position in any stocks mentioned. David Gardner owns shares of Amazon.com and Facebook. Tom Gardner owns shares of Facebook. The Motley Fool owns shares of Amazon.com and Facebook.

More on Investing

nugget gold
Metals and Mining Stocks

Must-Watch Gold Stocks Before Year-End

Gold prices have been going up for the better part of the year, and it is highly probable that this…

Read more »

CI Financial goes private
Bank Stocks

CI Financial Wants to Go Private: What Investors Need to Know

Will the deal actually go through, or might it face government scrutiny?

Read more »

Canadian dollars are printed
Dividend Stocks

Transform Your TFSA Into a Cash-Generating Machine With Just $28,000

Canadians can turn their TFSAs into a cash-generating machine with money equivalent to four years’ contribution limits.

Read more »

Investor wonders if it's safe to buy stocks now
Tech Stocks

Balancing the Risks and Rewards of Investing in AI Stocks

Choosing a safe AI stock can be challenging if you need help understanding the underlying technology, business model, and, by…

Read more »

A Canada Pension Plan Statement of Contributions with a 100 dollar banknote and dollar coins.
Retirement

Want the Maximum $1,346.60 CPP? Here’s the Income You Need

Most CPP users receive the average pension but have ways to boost their retirement income.

Read more »

open vault at bank
Bank Stocks

RBC vs. TD: Which Canadian Bank Stock Is the Better Buy?

Let's dive into whether Toronto-Dominion Bank (TSX:TD) or Royal Bank of Canada (TSX:RY) are the best picks in the banking…

Read more »

stock research, analyze data
Stocks for Beginners

Prediction: 2 Top Stock Picks to Beat the Market For Years to Come

Are you wondering what Canadian stocks could deliver predictable long-term returns? These two stocks are worth a bet for the…

Read more »

Silver coins fall into a piggy bank.
Dividend Stocks

Here’s the Average RRSP Balance at 45 in Canada

The RRSP is a strong tool for investors, but only if you invest in top stocks like this ETF for…

Read more »